184 related articles for article (PubMed ID: 9642377)
21. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
23. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
24. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
25. A study of heat shock protein 27 in endometrial carcinoma.
Geisler JP; Geisler HE; Tammela J; Miller GA; Wiemann MC; Zhou Z
Gynecol Oncol; 1999 Mar; 72(3):347-50. PubMed ID: 10053106
[TBL] [Abstract][Full Text] [Related]
26. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.
Lachance JA; Everett EN; Greer B; Mandel L; Swisher E; Tamimi H; Goff B
Gynecol Oncol; 2006 Jun; 101(3):470-5. PubMed ID: 16413048
[TBL] [Abstract][Full Text] [Related]
27. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.
Nofech-Mozes S; Ackerman I; Ghorab Z; Ismiil N; Thomas G; Covens A; Khalifa MA
Am J Clin Pathol; 2008 Jun; 129(6):912-7. PubMed ID: 18480008
[TBL] [Abstract][Full Text] [Related]
28. High-grade endometrial carcinoma in secretory endometrium in young women: a report of five cases.
Scurry J; Brand A; Sheehan P; Planner R
Gynecol Oncol; 1996 Feb; 60(2):224-7. PubMed ID: 8631542
[TBL] [Abstract][Full Text] [Related]
29. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
30. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma.
Erkanli S; Bolat F; Kayaselcuk F; Demirhan B; Kuscu E
Gynecol Oncol; 2007 Feb; 104(2):320-5. PubMed ID: 17030351
[TBL] [Abstract][Full Text] [Related]
31. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
Yin LJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
[TBL] [Abstract][Full Text] [Related]
33. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
34. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
Murray SK; Young RH; Scully RE
Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
[TBL] [Abstract][Full Text] [Related]
35. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
36. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
37. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
[TBL] [Abstract][Full Text] [Related]
39. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
40. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
